<p><b>OBJECTIVE</b>To rationalize the clinical use and
safety are some of the key issues in the
surveillance of
traditional Chinese medicine injections (TCMIs).</p><p><b>
METHOD</b>In this 2011 study, 240
medical records of
patients who had been discharged following
treatment with TCMIs between 1 and 12 month previously were randomly selected from
hospital records. Consistency between clinical use and the description of TCMIs was evaluated.
Research on
drug use and
adverse drug reactions/events using
logistic regression analysis was carried out.</p><p><b>RESULT</b>There was poor consistency between clinical use and
best practice advised in manuals on TCMIs. Over-
dosage and overly concentrated
administration of TCMIs occurred, with the outcome of modifying properties of the
blood.
Logistic regression analysis showed that,
drug concentration was a valid predictor for both
adverse drug reactions/events and benefits associated with TCMIs.</p><p><b>CONCLUSION</b>
Surveillance of rational clinical use and
safety of TCMIs finds that clinical use should be consistent with technical
drug manual specifications, and
drug use should draw on multi-layered
logistic regression analysis research to help avoid
adverse drug reactions/events.</p>